Multi-Frequency BIA and the Bio-Impedance Phase Angle
In 2026, the standard for professional assessment is Segmental Multi-Frequency Bioelectrical Impedance Analysis (SMF-BIA). Unlike early consumer models that sent a single 50 kHz signal through the feet, 2026 systems use a spectrum ranging from 1 kHz to 1000 kHz.
This allows the device to independently measure Extracellular Water (ECW) and Intracellular Water (ICW). A critical clinical metric derived from this is the Phase Angle (PhA). In 2026, the Phase Angle is used as a global biomarker for cellular integrity and health; a low PhA is a validated predictor of poor nutritional status and higher mortality in oncology and geriatric patients. By measuring the "reactance" and "resistance" of cell membranes, clinicians can detect cellular degradation weeks before it manifests as physical weight loss or muscle wasting.